Table 6.
Availability and stock-out of vaccines in health facilities that reported routinely storing vaccines
| Country | # of facilities that reported routinely storing vaccines | Availability on day of survey* (%) | # of facilities evaluated for previous months’ stock** | Stock-outs in facilities with all vaccines available on day of survey** (%) | |||||
|---|---|---|---|---|---|---|---|---|---|
| BCG | MMR | Pentavalent | Pneumonia | Rotavirus | BCG | MMR | |||
| Belize | 10 | 100 | 100 | 100 | *** | *** | 9 | 0.0 | 0.0 |
| El Salvador | 28 | 78.6 | 76.9 | 96.4 | 71.4 | 75.0 | *** | **** | **** |
| Guatemala | 55 | 96.4 | 96.4 | 96.4 | 92.7 | 90.9 | 33 | 3.0 | 3.0 |
| Honduras | 84 | 86.9 | 77.4 | 78.6 | 76.2 | 75.0 | 9 | 22.2 | 11.1 |
| Mexico | 37 | 73.0 | 83.8 | 78.4 | 40.5 | 78.4 | 7 | 42.9 | 57.1 |
| Nicaragua | 41 | 31.7 | 95.1 | 97.6 | 65.9 | 92.7 | 1 | 0.0 | 0.0 |
| Panama | 14 | 100 | 92.9 | 100 | 100 | 100 | 11 | 9.1 | 9.1 |
*Among facilities that reported routinely storing vaccines.
**Stock-out of vaccines in the three months prior to the day of the survey, not including availability on the day of the survey. These questions were only asked of facilities with all vaccines in stock on the day of the survey.
***Pneumonia and Rotavirus vaccines not measured in Belize.
****Stock-outs not captured for El Salvador. Influenza and Polio vaccines were observed but not included in analysis due to the fact that these vaccines are only administered at certain times of the year and therefore are not always expected to be in stock at facilities that routinely store other vaccines.